Related Experiment Video
Updated: May 31, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer
Paola De Luca1, Elba S Vazquez, Cristian P Moiola
1Laboratory of Cancer and Apoptosis, Department of Biological Chemistry, School of Scences, University of Buenos Aires, CONICET, Buenos Aires, Argentina.
Abstract:
BRCA1 plays numerous roles in the regulation of genome integrity and chemoresistance. Although BRCA1 interaction with key proteins involved in DNA repair is well known, its role as a coregulator in the transcriptional response to DNA damage remains poorly understood. In this study, we show that BRCA1 plays a central role in the transcriptional response to genotoxic stress in prostate cancer. BRCA1 expression mediates apoptosis, cell-cycle arrest, and decreased viability in response to doxorubicin treatment. Xenograft studies using human prostate carcinoma PC3 cells show that BRCA1 depletion results in increased tumor growth. A focused survey of BRCA1-regulated genes in prostate carcinoma reveals that multiple regulators of genome stability and cell-cycle control, including BLM, FEN1, DDB2, H3F3B, BRCA2, CCNB2, MAD2L1, and GADD153, are direct transcriptional targets of BRCA1. Furthermore, we show that BRCA1 targets GADD153 promoter to increase its transcription in response to DNA damage. Finally, GADD153 depletion significantly abrogates BRCA1 influence on cell-cycle progression and cell death in response to doxorubicin treatment. These findings define a novel transcriptional pathway through which BRCA1 orchestrates cell fate decisions in response to genotoxic insults, and suggest that BRCA1 status should be considered for new chemotherapeutic treatment strategies in prostate cancer.
Insights
BRCA1 (Breast Carcinoma gene 1) regulates prostate cancer cell fate and viability following DNA damage. Its role in transcriptional response to genotoxic stress impacts apoptosis, cell-cycle arrest, and tumor growth, suggesting new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- BRCA1's role in DNA repair and chemoresistance is established.
- Its function as a transcriptional coregulator in response to DNA damage is less understood.
Purpose of the Study:
- To investigate BRCA1's role in the transcriptional response to genotoxic stress in prostate cancer.
- To identify BRCA1-regulated genes involved in genome stability and cell-cycle control.
Main Methods:
- Utilized doxorubicin treatment in prostate cancer cell lines and xenograft models.
- Performed gene expression analysis and promoter assays.
- Investigated the impact of GADD153 depletion.
Main Results:
- BRCA1 expression mediates apoptosis, cell-cycle arrest, and decreased viability.
- BRCA1 depletion increased tumor growth in xenograft studies.
- Identified BLM, FEN1, BRCA2, and GADD153 as direct BRCA1 transcriptional targets.
Conclusions:
- BRCA1 orchestrates cell fate decisions via a novel transcriptional pathway in response to DNA damage.
- BRCA1 status is crucial for considering new chemotherapeutic strategies in prostate cancer.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Treatment Resistant Cancers
The Ras Gene
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation

